Cipla’s arm to acquire 100% stake in Anmarate

03 Apr 2017 Evaluate

Cipla Medpro South Africa (Pty), a wholly owned subsidiary of Cipla has signed an agreement on 30 March 2017 to acquire 100% stake in Anmarate (Pty), South Africa. The transaction is expected to complete before April 14, 2017. Anmarate, incorporated in 1996 in South Africa, is engaged in manufacturing and distribution of pharmaceutical products.

Cipla is a global pharmaceutical company, which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company has reported 43.85% rise in its consolidated net profit at Rs 374.83 crore for the quarter ended December 31, 2016, as compared to Rs 260.57 crore for the same quarter in the previous year.

Cipla Share Price

1396.40 48.70 (3.61%)
24-Apr-2024 14:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.10
Dr. Reddys Lab 5945.80
Cipla 1396.40
Zydus Lifesciences 935.25
Lupin 1583.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.